Clinical trial · Interventional
Group-based or Individual Information About Disease and Treatment Plan
Cancer Patients' Knowledge and Satisfaction After Group-based or Individual Information About Their Disease and Treatment Plan
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Problems recruiting patients (not willing, travel time, no respons)
Summary
Brief summary (as posted)
The main aim of the current study is to investigate whether the addition of a standardized,group-based educational program to the information provided by health care personnel improves cancer patients' knowledge level about their disease, planned treatment and common side-effects of the treatment. Secondary aims are to investigate if the addition of the educational program increases the likelihood of completing treatment as planned, reduces level of anxiety, reduces the frequency of serious side effects, increases patient reported health related quality of life, and increases the degree of patient satisfaction with respect to how they have received the information before, during and after treatment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Group information | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group and Individual information
- description
- The patients will receive two 1.5-2 hour standardized validated group information sessions in addition to regular information from their doctors and nurses.
- interventionNames
- Other: Group information
- type
- NO_INTERVENTION
- label
- Individual information
- description
- Standard information about disease and treatment from doctor and nurse given at 2 occasions.
Primary outcomes (3)
- measure
- Knowledge
- timeFrame
- 1 week
- description
- Knowledge questionnaires specially made for the study. Constructed as statements with response categories; correct, false and don´t know.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * Breast cancer patients that are candidates for adjuvant chemotherapy after surgery. * Prostate cancer patients that are candidates for curative radiotherapy * Signed informed consent * Patient expected to be able to complete the planned treatment and the study procedures * 18years or older Exclusion Criteria: -Patients not fulfilling inclusion criteria
References
Publications (1)
- DERIVEDBerger O, Gronberg BH, Loge JH, Kaasa S, Sand K. Cancer patients' knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study. BMC Cancer. 2018 Apr 3;18(1):381. doi: 10.1186/s12885-018-4164-5. PMID 29614997